IONS

Geary Richard S

Known title: EVP, Chief Development OfficerCIK: 0001442730

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 5, 2026

Cathie Wood adds to Ionis position amid RNA sector interest. Cathie Wood has increased her holdings in Ionis Pharmaceuticals as part of a broader bet on two stocks. This move highlights continued investor interest in RNA therapeutics, a sector currently drawing attention for its innovation potential. While the stock is trading near its 52-week low, the average analyst target remains significantly higher than the current price.

this person other insiders at IONS

Transaction History

IONS▲ Buy$837K
IONS▼ Sell$1.1M
IONS▲ Buy$1.1M
IONS▼ Sell$1.4M
IONS▲ Buy$45K
IONS▼ Sell$60K
IONS▲ Buy$49K
IONS▼ Sell$60K
IONS▲ Buy$44K
IONS▼ Sell$58K
IONS▲ Buy$55K
IONS▼ Sell$68K
IONS▲ Buy$2.1M
IONS▼ Sell$2.6M
IONS▲ Buy$2.0M
IONS▼ Sell$2.6M
IONS▼ Sell$1.5M
IONS▲ Buy$3.1M
IONS▼ Sell$3.8M
IONS▼ Sell$504K
IONS▼ Sell$5K
IONS▼ Sell$429K
IONS▼ Sell$12K
IONS▼ Sell$46K
IONS▲ Buy$0
IONS▼ Sell$232K
IONS▲ Buy$0
IONS▼ Sell$425
IONS▼ Sell$16K
IONS▼ Sell$16K
IONS▼ Sell$117K
IONS▼ Sell$21K
IONS▼ Sell$98K
IONS▲ Buy$0
IONS▼ Sell$370K
IONS▲ Buy$0
IONS▲ Buy$195K
IONS▼ Sell$203K
IONS▲ Buy$308K
IONS▼ Sell$323K
IONS▲ Buy$311K
IONS▼ Sell$323K
IONS▲ Buy$191K
IONS▼ Sell$203K
IONS▼ Sell$31
IONS▼ Sell$18K
IONS▼ Sell$78K
IONS▲ Buy$0
IONS▼ Sell$312K
IONS▲ Buy$0
IONS▼ Sell$18K
IONS▲ Buy$0
IONS▼ Sell$229K

We use analytics to understand how market-wall is used. No personal data is sold.